WAVE Life Sciences Ltd
WVEHealthcare|Biotechnology|Singapore
$6.26
-0.07 (-1.03%)
Tangible Book
$2.66
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (103)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| RA Capital Healthcare Fund LP | Director, 10% Owner | 2026-03-30 | BUY | 8,772,496 | $6.23 | $54652.7K |
| Francis Chris | See Remarks | 2026-02-26 | SELL | 33,194 | $15.05 | $499.6K |
| BOLNO PAUL | President and CEO | 2026-02-09 | SELL | 10,480 | $13.45 | $141K |
| Francis Chris | See Remarks | 2026-02-09 | SELL | 1,883 | $13.45 | $25.3K |
| Vargeese Chandra | See Remarks | 2026-02-09 | SELL | 3,228 | $13.45 | $43.4K |
| Moran Kyle | CFO | 2026-02-09 | SELL | 3,588 | $13.45 | $48.3K |
| Francis Chris | See Remarks | 2026-01-02 | SELL | 9,375 | $16.03 | $150.3K |
| GSK plc | 10% Owner | 2025-12-11 | BUY | 1,470,000 | $19 | $27930K |
| Moran Kyle | CFO | 2025-12-09 | SELL | 260,036 | $15.78 | $4103.4K |
| Wagner Heidi L | Director | 2025-12-08 | SELL | 14,000 | $13.5 | $189K |
| CORRIGAN MARK | Director | 2025-12-08 | SELL | 16,115 | $13.48 | $217.2K |
| HENRY CHRISTIAN O | Director | 2025-12-08 | SELL | 93,445 | $14.65 | $1369K |
| Rawcliffe Adrian | Director | 2025-12-08 | SELL | 42,000 | $15 | $630K |
| Tan Aik Na | Director | 2025-12-08 | SELL | 134,218 | $13.58 | $1822.7K |
| Verdine Gregory L. | Director | 2025-12-08 | SELL | 20,000 | $13.47 | $269.4K |
| Francis Chris | See Remarks | 2025-12-08 | SELL | 441,031 | $14.57 | $6425.8K |
| RA Capital Healthcare Fund LP | Director, 10% Owner | 2025-11-13 | BUY | 1,000 | $6.69 | $6.7K |
| Rawcliffe Adrian | Director | 2025-11-13 | SELL | 16,115 | $6.79 | $109.4K |
| Verdine Gregory L. | Director | 2025-08-22 | SELL | 10,000 | $10 | $100K |
| BOLNO PAUL | President and CEO | 2025-08-22 | SELL | 217,351 | $10.1 | $2195.2K |
| Tan Aik Na | Director | 2025-08-15 | SELL | 21,000 | $9.25 | $194.3K |
| HENRY CHRISTIAN O | Director | 2025-08-13 | SELL | 9,670 | $8.81 | $85.2K |
| TAKANASHI KEN | Director | 2025-08-05 | SELL | 4,872 | $8.75 | $42.6K |
| Tan Aik Na | Director | 2025-08-05 | SELL | 1,127 | $8.75 | $9.9K |
| Verdine Gregory L. | Director | 2025-06-13 | SELL | 30,000 | $6.95 | $208.5K |
| HENRY CHRISTIAN O | Director | 2025-03-20 | SELL | 10,500 | $9.77 | $102.6K |
| BOLNO PAUL | President and CEO | 2025-03-07 | SELL | 169,025 | $9.57 | $1617.6K |
| BOLNO PAUL | President and CEO | 2024-11-25 | SELL | 50,000 | $15 | $750K |
| BOLNO PAUL | President and CEO | 2024-11-15 | SELL | 51,234 | $14.32 | $733.7K |
| Francis Chris | See Remarks | 2024-11-08 | SELL | 36,000 | $16 | $576K |
| Francis Chris | See Remarks | 2024-10-16 | SELL | 208,836 | $13.67 | $2854.8K |
| BOLNO PAUL | President and CEO | 2024-10-16 | SELL | 90,474 | $15 | $1357.1K |
| GSK plc | 10% Owner | 2024-09-27 | BUY | 2,791,930 | $8 | $22335.4K |
| Moran Kyle | CFO | 2024-09-25 | SELL | 17,146 | $9 | $154.3K |
| BOLNO PAUL | President and CEO | 2024-08-21 | SELL | 48,366 | $5.78 | $279.6K |
| Moran Kyle | CFO | 2024-04-03 | SELL | 15,630 | $6.17 | $96.4K |
| RA Capital Healthcare Fund LP | Director, 10% Owner | 2023-12-11 | BUY | 1,000,000 | $5 | $5000K |
| RA Capital Healthcare Fund LP | Director, 10% Owner | 2023-12-11 | BUY | 1,000,000 | $5 | $5000K |
| GSK plc | 10% Owner | 2023-12-07 | BUY | 3,300,000 | $5 | $16500K |
| Moran Kyle | CFO | 2023-08-23 | SELL | 37,062 | $4.75 | $176K |
| Vargeese Chandra | See Remarks | 2023-02-16 | SELL | 10,249 | $4.03 | $41.3K |
| BOLNO PAUL | President and CEO | 2023-02-16 | SELL | 29,400 | $4.04 | $118.8K |
| Francis Chris | See Remarks | 2023-02-16 | SELL | 10,258 | $4.03 | $41.3K |
| Moran Kyle | CFO | 2023-02-16 | SELL | 9,729 | $4.04 | $39.3K |
| RA Capital Healthcare Fund LP | Director, 10% Owner | 2022-06-16 | BUY | 9,480,052 | $2.15 | $20382.1K |
| Vargeese Chandra | See Remarks | 2022-05-05 | SELL | 16,714 | $1.72 | $28.7K |
| BOLNO PAUL | President and CEO | 2022-05-05 | SELL | 33,501 | $1.72 | $57.6K |
| Moran Kyle | CFO | 2022-05-05 | SELL | 5,021 | $1.72 | $8.6K |
| Panzara Michael A. | See Remarks | 2022-05-05 | SELL | 16,714 | $1.72 | $28.7K |
| Francis Chris | See Remarks | 2022-05-05 | SELL | 10,867 | $1.72 | $18.7K |
| Moran Kyle | CFO | 2022-02-16 | SELL | 9,204 | $2.31 | $21.3K |
| Francis Chris | See Remarks | 2022-02-16 | SELL | 10,123 | $2.31 | $23.4K |
| Vargeese Chandra | Chief Technology Officer | 2022-02-16 | SELL | 10,603 | $2.32 | $24.6K |
| BOLNO PAUL | President and CEO | 2022-02-16 | SELL | 33,150 | $2.32 | $76.9K |
| Panzara Michael A. | See Remarks | 2022-02-16 | SELL | 10,603 | $2.31 | $24.5K |
| Francis Chris | See Remarks | 2021-02-16 | SELL | 2,698 | $10.57 | $28.5K |
| BOLNO PAUL | President and CEO | 2021-02-16 | SELL | 11,205 | $10.57 | $118.4K |
| Panzara Michael A. | See Remarks | 2021-02-16 | SELL | 2,929 | $10.57 | $31K |
| Vargeese Chandra | Chief Technology Officer | 2021-02-16 | SELL | 3,145 | $10.57 | $33.2K |
| Moran Kyle | CFO | 2021-02-16 | SELL | 1,722 | $10.57 | $18.2K |
| BOLNO PAUL | President and CEO | 2020-09-15 | SELL | 100,000 | $15 | $1500K |
| BOLNO PAUL | President and CEO | 2020-08-25 | SELL | 25,000 | $12 | $300K |
| BOLNO PAUL | President and CEO | 2020-07-02 | SELL | 147,577 | $10.3 | $1520K |
| Francis Chris | See Remarks | 2020-02-18 | SELL | 2,708 | $7.85 | $21.3K |
| Vargeese Chandra | Senior VP, Drug Discovery | 2020-02-18 | SELL | 3,188 | $7.85 | $25K |
| Panzara Michael A. | Chief Medical Officer | 2020-02-18 | SELL | 2,981 | $7.85 | $23.4K |
| BOLNO PAUL | President and CEO | 2020-02-18 | SELL | 11,451 | $7.85 | $89.9K |
| Gaiero David G | Interim CFO | 2020-02-03 | SELL | 651 | $7 | $4.6K |
| Vargeese Chandra | Senior VP, Drug Discovery | 2019-12-03 | SELL | 6,000 | $35 | $210K |
| Verdine Gregory L. | Director | 2019-11-20 | SELL | 30,039 | $30.63 | $920.1K |
| Panzara Michael A. | Chief Medical Officer | 2019-07-05 | SELL | 3,058 | $26.94 | $82.4K |
| BOLNO PAUL | President and CEO | 2019-03-15 | SELL | 50,000 | $45.48 | $2274K |
| Panzara Michael A. | Franchise Lead, Neurology | 2019-03-11 | SELL | 7,000 | $48 | $336K |
| Regnante Keith | CFO | 2019-02-19 | SELL | 1,298 | $36.84 | $47.8K |
| Panzara Michael A. | Franchise Lead, Neurology | 2019-02-19 | SELL | 1,837 | $36.84 | $67.7K |
| BOLNO PAUL | President and CEO | 2019-02-19 | SELL | 7,733 | $36.4 | $281.5K |
| Vargeese Chandra | Senior VP, Drug Discovery | 2019-02-19 | SELL | 2,055 | $36.84 | $75.7K |
| Francis Chris | See Remarks | 2019-02-19 | SELL | 1,709 | $36.84 | $63K |
| RA CAPITAL MANAGEMENT, LLC | Director, 10% Owner | 2019-01-24 | BUY | 263,158 | $38 | $10000K |
| Verdine Gregory L. | Director | 2018-11-14 | SELL | 15,000 | $38.86 | $582.9K |
| Francis Chris | See Remarks | 2018-09-25 | SELL | 11,575 | $56 | $648.2K |
| Regnante Keith | CFO | 2018-09-24 | SELL | 29,500 | $55 | $1622.5K |
| Vargeese Chandra | Senior VP, Drug Discovery | 2018-09-24 | SELL | 3,000 | $55 | $165K |
| Francis Chris | See Remarks | 2018-07-09 | SELL | 24,496 | $37.27 | $913K |
| Francis Chris | See Remarks | 2018-06-01 | SELL | 48,992 | $46.75 | $2290.4K |
| BOLNO PAUL | President and CEO | 2018-05-30 | SELL | 31,711 | $45 | $1427K |
| BOLNO PAUL | President and CEO | 2018-05-02 | SELL | 18,289 | $45 | $823K |
| Francis Chris | See Remarks | 2018-02-20 | SELL | 21,639 | $55.4 | $1198.8K |
| BOLNO PAUL | President and CEO | 2018-02-16 | SELL | 2,714 | $51.5 | $139.8K |
| Panzara Michael A. | Franchise Lead, Neurology | 2018-02-16 | SELL | 511 | $52.1 | $26.6K |
| Regnante Keith | CFO | 2018-02-16 | SELL | 316 | $51.85 | $16.4K |
| Vargeese Chandra | See Remarks | 2018-02-15 | SELL | 2,000 | $50 | $100K |
| Panzara Michael A. | Franchise Lead, Neurology | 2018-02-15 | SELL | 18,750 | $50 | $937.5K |
| Vargeese Chandra | See Remarks | 2018-01-23 | SELL | 2,000 | $40 | $80K |
| Vargeese Chandra | See Remarks | 2017-11-22 | SELL | 1,500 | $35 | $52.5K |
| RA CAPITAL MANAGEMENT, LLC | Director, 10% Owner | 2017-11-14 | BUY | 423,398 | $23.34 | $9882.1K |
| Tanaka Masaharu | Director, 10% Owner | 2017-09-18 | SELL | 20,747 | $24.21 | $502.3K |
| Panzara Michael A. | Franchise Lead, Neurology | 2017-07-12 | SELL | 7,414 | $16.67 | $123.6K |
| Tanaka Masaharu | Director, 10% Owner | 2017-03-29 | SELL | 433,825 | $24.91 | $10806.6K |
| Verdine Gregory L. | Director | 2016-06-15 | SELL | 52,000 | $16.7 | $868.4K |
| RA CAPITAL MANAGEMENT, LLC | Director, 10% Owner | 2015-11-16 | BUY | 1,875,000 | $16 | $30000K |
| TAKANASHI KEN | Director, 10% Owner | 2015-11-16 | BUY | 125,000 | $16 | $2000K |
| Tanaka Masaharu | Director, 10% Owner | 2015-11-16 | BUY | 76,250 | $16 | $1220K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked